主动脉旁脂肪组织释放IL-6增加LDL受体缺陷小鼠动脉僵硬度的研究
[Abstract]:Chronic cardiovascular disease is a common chronic disease with the highest morbidity and mortality in the disease spectrum. It is reported that 23.3 million people will die of cardiovascular diseases worldwide by 2030. Cardiovascular diseases lead to huge medical and health expenditures, especially in low-income developing countries. From 2005 to 2015, China has invested about 558 billion US dollars in the prevention and treatment of cardiovascular diseases. Therefore, it is of great social significance to find a way to prevent the occurrence and development of cardiovascular diseases. Hyperlipidemia is often associated with increased arterial stiffness, which increases the incidence of cardiovascular events. Early intervention of arterial stiffness in patients with hyperlipidemia is of great significance in delaying and controlling the progression of cardiovascular disease. Studies have shown that hyperlipidemia can increase arterial stiffness, but whether hyperlipidemia passes through. In addition, previous studies have found that para-aortic adipose tissue (PAT) releases a variety of inflammatory mediators and cytokines, including interleukin-6 (IL-6), and IL-6 is an important cause of increased arterial stiffness. During the disease, PAT increased arterial stiffness by releasing IL-6.
LDL receptor deficient mice (LDLr-/-mice) are typical hyperlipidemia model mice. The purpose of this study was to investigate the effect of hyperlipidemia on arterial stiffness and its mechanism. Firstly, in order to clarify that hyperlipidemia increases arterial stiffness by affecting the expression of extracellular matrix protein in arterial wall, this study selected LDLr-/-mice as the main research object. LDLr - / - mice were selected as the research object, and wild type (WT) mice were used as the control group. The general indexes (body weight, heart weight, adipose tissue weight, lean tissue weight and systolic blood pressure level), blood lipid, arterial pulse wave velocity (aPWV), aortic elastic modulus and arterial stiffness related protein (collagen, glycosylation) were observed and compared between the two groups. Secondly, in order to clarify the effect of LDLr - / - on aortic stiffness, we isolated the aortas of LDLr - / - mice and WT mice (with or without PAT) and divided them into the following four groups: WT group; WT + PAT group; LDLr - / - group; LDLr - / - group; LDLr - / -+ PAT group. Compared with the four groups of mice, the aortic elastic modulus, aortic collagen, elastin and the expression level of glycation end products were measured. The changes of aortic elastic modulus were detected and compared between the two groups. Then, the PATs of LDLr - / - mice and WT mice were separated and cultured in vitro. The PATs were divided into the following two groups: WT group and LDLr - / - group. The arterial segments were divided into the following two groups: control group, IL-6 group, PAT + control group, PAT + IL-6Ab group, and PAT + IL-6Ab group. The change of elastic modulus of aortic segments.
The results showed that: (1) There were no significant differences in body weight, heart weight, adipose tissue weight, lean tissue weight and systolic blood pressure between LDLr - / - mice and WT mice (P 0.05); (2) Total cholesterol and triglyceride levels in LDLr - / - mice were significantly higher than those in WT mice (P 0.05); (3) aortic stiffness of LDLr - / - mice (aPWV, aPWV, triglyceride level). Compared with WT group, the aortic stiffness of LDLr-/- group was significantly increased, and the aortic stiffness of LDLr-/-+PAT group was further increased, the difference was statistically significant (P 0.05). (5) Compared with WT mice, PAT conditioned medium from LDLr - / - mice significantly increased aortic stiffness of WT mice, the difference was statistically significant (P 0.05); (6) In LDLr - / - mice aortic wall media with PAT culture, the expression of collagen I in adventitia increased, the expression of AGEs in adventitia increased, and the expression of elastin decreased, the difference was statistically significant (P 0.05). Significance (P 0.05); (7) The size of PAT cells in LDLr - / - mice was significantly larger than that in WT mice, and the difference was statistically significant (P 0.05); (8) The effect of conditioned medium of LDLr - / - mice PAT on aortic stiffness was higher than that in subcutaneous adipose tissue, paraepididymal adipose tissue conditioned medium; (9) LDLr - / - mice PAT secreted more IL-6 than WT mice PAT, and Moreover, IL-6 increased aortic stiffness. IL-6 antibody could reduce the increase of arterial stiffness caused by PAT.
The results showed that: (1) the expression of extracellular matrix protein in arterial wall of LDLr - / - mice was unbalanced, and the degree of aortic stiffness was significantly higher than that of WT mice; (2) LDLr - / - mice PAT promoted the increase of aortic stiffness; (3) LDLr - / - mice PAT had stronger effect on aortic stiffness than subcutaneous adipose tissue, paraepididymal fat. The PAT of PAT. (4) LDLr-/- mice in fat tissue and WT mice increased the arterial stiffness through releasing IL-6.
【学位授予单位】:吉林大学
【学位级别】:博士
【学位授予年份】:2015
【分类号】:R543
【共引文献】
相关期刊论文 前10条
1 谷婧;;健步走结合瑜伽运动对大同市中老年女性体适能的影响[J];搏击(体育论坛);2011年09期
2 杨清武,王景周,王琳,周红杰,高东;急性脑血管病的代谢紊乱特点及相关因素的多元回归分析[J];重庆医学;2004年06期
3 刘鹏举;马方;;Prader-Willi综合征研究现状[J];中国当代儿科杂志;2008年04期
4 王永亮;穆林;陈佳纬;付晓宝;连艳凯;赵树梅;吴永全;;冠心病患者冠状动脉病变程度与脉搏波传导速度的相关性研究[J];中国医药导刊;2011年07期
5 刘恒国;罗南萍;白璐;王瑞山;;老年代谢综合征与VEGF的关系[J];放射免疫学杂志;2006年06期
6 陆泽元,杨冀衡,任雪鸿,许我先,邹钢;深圳市部分成人体重指数与血脂的关系[J];广东医学;2001年09期
7 李俊峰;汤绍辉;杨冬华;杨见权;;非酒精性脂肪肝与胆石症的关系[J];广东医学;2006年07期
8 何煜;黄龙;张琰;梁海冰;;代谢综合征患者颈动脉粥样硬化的超声检测[J];广西医科大学学报;2006年03期
9 胡世红;代谢综合征成份与颈动脉内膜中层厚度关系研究进展[J];广西医学;2002年09期
10 孙晓花;刘闺男;张晶;;Egr-1的诱骗性寡脱氧核苷酸抑制大鼠颈总动脉损伤后MMP-2的表达[J];中国组织化学与细胞化学杂志;2013年05期
相关会议论文 前7条
1 冯磊;;脂联素及其受体基因多态性与冠心病相关性[A];玉溪市第十一届检验医学学术年会暨科技成果推广会论文汇编[C];2014年
2 陈婧;杨惠民;孙庆玲;杭海燕;薛晓琳;叶超;赵赫;;脾肾阳虚证和痰浊阻遏证血脂异常患者肿瘤坏死因子α的水平变化、血脂指标特点及其与中医证候积分的相关性研究[A];中华中医药学会第十二次中医药防治老年病学术研讨会暨老年病防治科研进展学习班会议论文集[C];2014年
3 潘铨;陈礼平;姚纯俭;项伟忠;章丽丽;王志颖;;畲药食凉茶组方对老年高血压病患者颈动脉内膜-中膜厚度的影响[A];“新成果·新进展·新突破”中华中医药学会2013年学术年会、第三次中华中医药科技成果论坛论文集[C];2013年
4 陈婧;杨惠民;孙庆玲;杭海燕;薛晓琳;叶超;赵赫;;脾肾阳虚证和痰浊阻遏证血脂异常患者肿瘤坏死因子α的水平变化、血脂指标特点及其与中医证候积分的相关性研究[A];第十二次中医药防治老年病学术研讨会暨老年病防治科研进展学习班会议论文集[C];2014年
5 周庆蓉;邹文淑;;替米沙坦治疗老年高血压合并糖耐量异常患者的血脂影响[A];中国转化医学和整合医学研讨会(广州站)论文综合刊[C];2015年
6 何华;贾平;韩福生;李勇;张海波;曾玉杰;;佩尔和硝普钠治疗国人高血压急症的临床对照研究[A];2014年中华中医药学会急诊分会年会暨急诊医学培训班论文集[C];2014年
7 秦汉;胡志希;李琳;吕佳;杨杨;张易;;雪莲通脉丸对冠心病气虚血瘀证小鼠血管内皮细胞功能相关指标ET-1、NO、ACE的影响[A];第九次全国中西医结合诊断学术研讨会论文集[C];2015年
相关博士学位论文 前10条
1 梁亚军;儿童期高血压预测成年高血压及靶器官损害的前瞻性研究[D];北京协和医学院;2011年
2 揭国良;普洱茶抗氧化作用及减肥作用的研究[D];浙江大学;2008年
3 李平;阿托伐他汀和硒对SAA作用下血管内皮细胞功能的影响[D];郑州大学;2013年
4 王艳;中年女性体力活动与端粒体的相关性及“万步行”干预效果的研究[D];北京体育大学;2013年
5 聂少芳;9p21.3多态性位点与中国汉族人群冠心病、2型糖尿病的关联研究[D];华中科技大学;2013年
6 黄景慧;埃他卡林选择性抗高血压作用分子机制的研究[D];中国人民解放军军事医学科学院;2013年
7 冯帆;药物/候选药物细胞表型谱研究[D];中国人民解放军军事医学科学院;2013年
8 许耘红;睡眠剥夺与动脉粥样硬化病变的相关性研究[D];南方医科大学;2011年
9 王冬雪;血浆HDL中蛋白质组分与冠心病的关系及应用他汀类药后的变化研究[D];北京协和医学院;2013年
10 熊兴江;补肾降压理论及补肾降压方对自发性高血压大鼠miR-1调控心室肥厚ERK通路的影响[D];中国中医科学院;2013年
相关硕士学位论文 前10条
1 王魁风;视黄醇结合蛋白4、高敏C反应蛋白与冠心病及冠脉病变特征的关系[D];郑州大学;2010年
2 黄慧钟;同型半胱氨酸与糖代谢异常的相关性研究[D];南昌大学;2011年
3 董霞;中北大学教授生活方式与血脂水平、血脂异常患病率的相关研究[D];中北大学;2012年
4 周晋萌;血清胰岛素样生长因子-1及胰淀素在阻塞性睡眠呼吸暂停低通气综合征合并2型糖尿病患者中的变化及意义[D];山西医科大学;2012年
5 徐建萍;阻塞性睡眠呼吸暂停综合征患者血清瘦素水平与胰岛素抵抗的关系[D];第四军医大学;2005年
6 王晓梅;2型糖尿病患者C反应蛋白水平与代谢综合征的相关性研究[D];山东大学;2005年
7 刘f ;阻塞性睡眠呼吸暂停低通气综合征患者血管内皮功能和胰岛素抵抗研究[D];山东大学;2005年
8 潘伟;代谢综合征并急性冠脉综合征与冠状动脉病变关系的临床研究[D];昆明医学院;2005年
9 杨秀云;经鼻持续气道正压通气治疗对OSAHS患者胰岛素抵抗性的影响[D];浙江大学;2006年
10 姜洪娟;血浆总同型半胱氨酸与糖代谢异常及代谢综合症的相关性研究[D];山东大学;2006年
本文编号:2198750
本文链接:https://www.wllwen.com/yixuelunwen/xxg/2198750.html